Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Advertising (263)
- Legislation (86)
- COVID-19 (66)
- Compliance and enforcement (56)
- Vaping hub (48)
- Manufacturing (31)
- Import and export (24)
- Labelling and packaging (21)
- Medicinal cannabis hub (20)
- Scheduling (national classification system) (19)
- Safety monitoring and information (15)
- Weight loss products (7)
- Shortages and supply disruptions (4)
- Cosmetics (3)
- Committees and advisory bodies (2)
- Prescription opioids hub (2)
- Sunscreens (2)
- Unique Device Identification (UDI) hub (2)
- Clinical trials (1)
- Fees and payments (1)
- Urogynaecological (transvaginal) surgical mesh hub (1)
Search
720 result(s) found, displaying 501 to 525
-
Media releasesThe TGA has issued three infringement notices totalling $39,960 to Melbourne-based company Italian Princess Coffee Brands Pty Ltd (trading as Zafe Zone)
-
Media releasesThe TGA has issued three infringement notices to Brisbane clothing company Lorna Jane Pty Ltd
-
Media releasesThe TGA has granted provisional approval to remdesivir ("Veklury", Gilead Sciences Pty Ltd) as the first treatment option for COVID-19.
-
Media releasesTGA compliance and enforcement in 2019-20
-
Regulatory decision noticesGuidance to assist sponsors when using the code tables for GMP Clearance applications
-
Regulatory decision noticesInformation to assist overseas manufactures who may undergo a remote Good Manufacturing Practice inspection during the COVID-19 pandemic
-
Media releasesFrom 1 July 2020 medicine ads in specified media no longer require pre-approval
-
Media releasesThe TGA has issued an infringement notice for $12,600 to Sydney-based company Arborvitae Health and Wellbeing for alleged unlawful advertising in relation to COVID-19.
-
Media releasesThe TGA has issued two infringement notices totalling $25,200 to Sydney-based company Pfeffer Contracting for alleged unlawful advertising in relation to COVID-19.
-
Media releasesThe TGA has issued two infringement notices totalling $25,200 to Sydney-based company Australian Chemical Research
-
Media releasesThe TGA has issued three infringement notices totalling $7,560 to a woman based in Brisbane
-
Media releasesNo lasting increase in consumption following up-scheduling of low-dose products
-
Media releasesReminder of changes for those who advertise medicines to the public using television, radio, print media, cinema, billboards or other public displays
-
Media releasesThe TGA has commenced a review of complaints received alleging non-compliant advertising of medicinal cannabis products to the public
-
Media releasesThe International Coalition of Medicines Regulatory Authorities aims to provide healthcare professionals with important messages regarding vaccines
-
Media releasesThe International Coalition of Medicines Regulatory Authorities highlights the importance of vaccines for consumers
-
Media releasesThe TGA has issued two infringement notices to Sydney-based company Inskin Cosmedics Group Pty Ltd
-
Media releasesNet Pharmacy fined $214,200 for alleged unlawful advertising
-
Media releasesThe TGA has issued twelve infringement notices to a Victorian-based pharmacist for alleged unlawful advertising of therapeutic goods
-
Media releasesThe TGA has issued five infringement notices to Sydney-based company Chemforce Pty Ltd
-
Media releasesTGA taking action on sunscreens tested by AMA Laboratories
-
Hydrogen Technologies fined $50,400 for alleged advertising breaches including reference to COVID-19
Media releasesThe TGA has issued four infringement notices totalling $50,400 to Cairns based company Hydrogen Technologies Pty Ltd for alleged advertising breaches including reference to COVID-19 -
Regulatory decision noticesThe Therapeutic Goods (Permissible Ingredients) Determination has been updated.
-
Media releasesThe Federal Court of Australia has made orders restraining MMS Australia from advertising and supplying goods containing certain potentially dangerous substances until a further hearing next week
-
Media releasesThe reforms will enable the safe and effective prescribing and use of opioids while maintaining access for patients who need them.